Definitive Healthcare/$DH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Definitive Healthcare

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Ticker

$DH
Primary listing

Industry

Health Care Technology

Employees

782

ISIN

US24477E1038

DH Metrics

BasicAdvanced
$409M
-
-$4.42
1.48
-

What the Analysts think about DH

Analyst ratings (Buy, Hold, Sell) for Definitive Healthcare stock.

Bulls say / Bears say

Definitive Healthcare is a leader in the healthcare commercial intelligence market, managing extensive data including 300 million patient profiles and 2 million healthcare providers, positioning it to capitalize on a $10 billion market opportunity. (seekingalpha.com)
BTIG initiated coverage with a 'Buy' rating and a $7.00 price target, highlighting the company's comprehensive data collection and analytics platform that supports various sectors within the healthcare industry. (investing.com)
Analysts anticipate Definitive Healthcare to achieve breakeven by 2026, projecting a positive profit of $41 million, indicating strong growth potential. (simplywall.st)
Barclays downgraded Definitive Healthcare to 'Underweight' and reduced the price target to $3.00, reflecting concerns over the company's performance and market position. (americanbankingnews.com)
The company reported a quarter-over-quarter decrease in sales of 5.53%, indicating potential challenges in maintaining revenue growth. (uspostnews.com)
Definitive Healthcare faces internal restructuring and market pressures, with analysts expressing concerns about the company's ability to execute a successful turnaround under new leadership. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.

DH Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

DH Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DH

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs